Probing the Interface of HIV and Inflammaging
- PMID: 33709322
- DOI: 10.1007/s11904-021-00547-0
Probing the Interface of HIV and Inflammaging
Abstract
Purpose of review: Systemic inflammation increases as a consequence of aging (inflammaging) and contributes to age-related morbidities. Inflammation in people living with HIV is elevated compared with the general population even after prolonged suppression of viremia with anti-retroviral therapy. Mechanisms that contribute to inflammation during aging and in treated HIV disease are potentially interactive, leading to an exaggerated inflammatory phenotype in people with HIV.
Recent findings: Recent studies highlight roles for anti-retroviral therapy, co-infections, immune system alterations, and microbiome perturbations as important contributors to HIV-associated inflammation. These factors likely contribute to increased risk of age-related morbidities in people living with HIV. Understanding mechanisms that exaggerate the inflammaging process in people with HIV may lead to improved intervention strategies, ultimately, extending both lifespan and healthspan.
Keywords: Aging; HIV disease; Inflammation.
Similar articles
-
Aging with HIV in the ART era.Semin Diagn Pathol. 2017 Jul;34(4):384-397. doi: 10.1053/j.semdp.2017.04.002. Epub 2017 Apr 6. Semin Diagn Pathol. 2017. PMID: 28552209 Review.
-
How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.Front Immunol. 2019 Jun 19;10:1378. doi: 10.3389/fimmu.2019.01378. eCollection 2019. Front Immunol. 2019. PMID: 31275317 Free PMC article. Review.
-
Ageing and inflammation in patients with HIV infection.Clin Exp Immunol. 2017 Jan;187(1):44-52. doi: 10.1111/cei.12814. Epub 2016 Aug 9. Clin Exp Immunol. 2017. PMID: 27198731 Free PMC article. Review.
-
Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART.Viruses. 2019 Feb 27;11(3):200. doi: 10.3390/v11030200. Viruses. 2019. PMID: 30818749 Free PMC article. Review.
-
Pharmacological and Behavioral Interventions to Mitigate Premature Aging in Patients with HIV.Curr HIV/AIDS Rep. 2023 Dec;20(6):394-404. doi: 10.1007/s11904-023-00677-7. Epub 2023 Nov 2. Curr HIV/AIDS Rep. 2023. PMID: 37917387 Review.
Cited by
-
Inflammation, Immune Senescence, and Dysregulated Immune Regulation in the Elderly.Front Aging. 2022 Apr 27;3:840827. doi: 10.3389/fragi.2022.840827. eCollection 2022. Front Aging. 2022. PMID: 35821823 Free PMC article. Review.
-
HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model.J Virol. 2023 Dec 21;97(12):e0159523. doi: 10.1128/jvi.01595-23. Epub 2023 Nov 30. J Virol. 2023. PMID: 38032195 Free PMC article.
-
Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation.J Neuroinflammation. 2022 Dec 8;19(1):293. doi: 10.1186/s12974-022-02658-w. J Neuroinflammation. 2022. PMID: 36482436 Free PMC article.
-
An Overview of Miami CDEIPI and a Showcase of Team Science and Cutting-Edge Research Driven by Students.J Acquir Immune Defic Syndr. 2023 Oct 1;94(2S):S93-S98. doi: 10.1097/QAI.0000000000003254. J Acquir Immune Defic Syndr. 2023. PMID: 37707855 Free PMC article.
-
Accelerated aging in people living with HIV: The neuroimmune feedback model.Brain Behav Immun Health. 2024 Feb 5;36:100737. doi: 10.1016/j.bbih.2024.100737. eCollection 2024 Mar. Brain Behav Immun Health. 2024. PMID: 38356933 Free PMC article.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- Antiretroviral Therapy Cohort C. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293–9. https://doi.org/10.1016/S0140-6736(08)61113-7 . - DOI
-
- Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PloS one. 2013;8(12):e81355. https://doi.org/10.1371/journal.pone.0081355 . - DOI - PubMed - PMC
-
- •• Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, et al. Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016. JAMA Network Open. 2020;3(6):e207954. https://doi.org/10.1001/jamanetworkopen.2020.7954 This matched cohort study of 39000 HIV-infected patients provides evidence of healthspan deficit in PWH. - DOI - PubMed - PMC
-
- Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. New Engl J Med. 1990;322(3):166–72. https://doi.org/10.1056/NEJM199001183220305 . - DOI - PubMed
-
- Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1988). 1993;6(8):904–12.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials